The production of vaccines using mammalian cell culture is a major application in biotechnology. As an example, we investigate a production process for influenza vaccines produced in adherently growing mammalian MDCK cells [Genzel et al., 2004]. The process consists of a cell growth phase with a duration about 96 h followed by a virus replication phase, which requires about 72 h. Typically, cell numbers and various metabolite concen-trations were determined. In addition, flow cytometry [Darzynkiewicz et al., 1997] was used to determine the cell cycle states 'G0/G1', 'S' and 'G2/M'. Also, oxygen uptake rates during the cell growth phase were monitored. Typically, local maxima in the oxygen uptake rates during cell growth could be observed. R...
To describe the growth behavior of anchorage-dependent mammalian cells in microcarrier systems, vari...
To describe the growth behavior of anchorage-dependent mammalian cells in microcarrier systems, vari...
Our aim is the design and optimisation of equine influenza vaccine production processes for the amel...
The production of vaccines using mammalian cell culture is a major application in biotechnology. As ...
Product yields of biologicals such as monoclonal antibodies, recombinant proteins and vaccines produ...
Product yields of biologicals such as monoclonal antibodies, recombinant proteins and vaccines produ...
Product yields of biologicals such as monoclonal antibodies, recombinant proteins and vaccines produ...
Many existing as well as potential new drugs such as monoclonal antibodies, recombinant proteins or ...
Many existing as well as potential new drugs such as monoclonal antibodies, recombinant proteins or ...
Many existing as well as potential new drugs such as monoclonal antibodies, recombinant proteins or ...
Every year epidemic influenza virus infections cause up to 500.000 deaths and 3 to 5 million cases o...
Increasing efforts are made to establish mammalian cell culture as host system for the propagation o...
Increasing efforts are made to establish mammalian cell culture as host system for the propagation o...
Every year epidemic influenza virus infections cause up to 500.000 deaths and 3 to 5 million cases o...
Increasing efforts are made to establish mammalian cell culture as host system for the propagation o...
To describe the growth behavior of anchorage-dependent mammalian cells in microcarrier systems, vari...
To describe the growth behavior of anchorage-dependent mammalian cells in microcarrier systems, vari...
Our aim is the design and optimisation of equine influenza vaccine production processes for the amel...
The production of vaccines using mammalian cell culture is a major application in biotechnology. As ...
Product yields of biologicals such as monoclonal antibodies, recombinant proteins and vaccines produ...
Product yields of biologicals such as monoclonal antibodies, recombinant proteins and vaccines produ...
Product yields of biologicals such as monoclonal antibodies, recombinant proteins and vaccines produ...
Many existing as well as potential new drugs such as monoclonal antibodies, recombinant proteins or ...
Many existing as well as potential new drugs such as monoclonal antibodies, recombinant proteins or ...
Many existing as well as potential new drugs such as monoclonal antibodies, recombinant proteins or ...
Every year epidemic influenza virus infections cause up to 500.000 deaths and 3 to 5 million cases o...
Increasing efforts are made to establish mammalian cell culture as host system for the propagation o...
Increasing efforts are made to establish mammalian cell culture as host system for the propagation o...
Every year epidemic influenza virus infections cause up to 500.000 deaths and 3 to 5 million cases o...
Increasing efforts are made to establish mammalian cell culture as host system for the propagation o...
To describe the growth behavior of anchorage-dependent mammalian cells in microcarrier systems, vari...
To describe the growth behavior of anchorage-dependent mammalian cells in microcarrier systems, vari...
Our aim is the design and optimisation of equine influenza vaccine production processes for the amel...